J.P. Morgan Private Wealth Advisors’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,352
| Closed | -$246K | – | 1981 |
|
|
2022
Q4 | $246K | Sell |
3,352
-42
| -1% | -$3.08K | ﹤0.01% | 1734 |
|
|
2022
Q3 | $258K | Buy |
3,394
+298
| +10% | +$22.7K | ﹤0.01% | 1720 |
|
|
2022
Q2 | $215K | Buy |
3,096
+80
| +3% | +$5.56K | ﹤0.01% | 1794 |
|
|
2022
Q1 | $250K | Sell |
3,016
-766
| -20% | -$63.5K | ﹤0.01% | 1830 |
|
|
2021
Q4 | $284K | Buy |
3,782
+53
| +1% | +$3.98K | ﹤0.01% | 1764 |
|
|
2021
Q3 | $433K | Buy |
3,729
+250
| +7% | +$29K | ﹤0.01% | 1556 |
|
|
2021
Q2 | $772K | Buy |
3,479
+1,854
| +114% | +$411K | ﹤0.01% | 1316 |
|
|
2021
Q1 | $215K | Sell |
1,625
-2,347
| -59% | -$311K | ﹤0.01% | 1657 |
|
|
2020
Q4 | $687K | Buy |
+3,972
| New | +$687K | ﹤0.01% | 1154 |
|
|
2020
Q2 | – | Sell |
-3,702
| Closed | -$249K | – | 1584 |
|
|
2020
Q1 | $249K | Sell |
3,702
-1,250
| -25% | -$84.1K | ﹤0.01% | 1201 |
|
|
2019
Q4 | $417K | Buy |
4,952
+300
| +6% | +$25.3K | ﹤0.01% | 1115 |
|
|
2019
Q3 | $348K | Buy |
+4,652
| New | +$348K | ﹤0.01% | 1134 |
|
|
2019
Q2 | – | Sell |
-16,800
| Closed | -$809K | – | 1437 |
|
|
2019
Q1 | $809K | Buy |
+16,800
| New | +$809K | ﹤0.01% | 862 |
|
|
2018
Q4 | – | Sell |
-30,700
| Closed | -$1.61M | – | 1545 |
|
|
2018
Q3 | $1.61M | Buy |
+30,700
| New | +$1.61M | 0.01% | 675 |
|